Actively Recruiting
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
Led by Baker Heart and Diabetes Institute · Updated on 2025-12-04
748
Participants Needed
2
Research Sites
132 weeks
Total Duration
On this page
Sponsors
B
Baker Heart and Diabetes Institute
Lead Sponsor
W
Western Health, Australia
Collaborating Sponsor
AI-Summary
What this Trial Is About
REDEEM-CAD is a prospective multi-centre study of CAD risk evaluation and management in cancer survivors 40-70 years with chemotherapy or radiotherapy \>5 years ago.
CONDITIONS
Official Title
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of cancer treated more than 5 years ago with chemotherapy and/or radiotherapy
- Age between 40 and 70 years
- Cancer types mainly include breast cancer, Hodgkin's lymphoma, and prostate cancer
You will not qualify if you...
- Unable to provide written informed consent
- Known coronary artery disease at recruitment
- History of previous coronary artery disease
- Unable to get interpretable CT images
- Contraindications, intolerance to, or currently taking statin therapy
- Life expectancy less than 12 months due to cancer or other medical conditions, including pregnancy
- Any medical condition deemed by investigators to make participation inappropriate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tom Marwick
Hobart, Tasmania, Australia, 7000
Actively Recruiting
2
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia, 3004
Actively Recruiting
Research Team
T
Tom Marwick, MBBS,PhD,MPH
CONTACT
L
Lisa Riddell
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here